These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36252310)

  • 1. Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure.
    Compagner CT; Wysocki CR; Reich EK; Zimmerman LH; Holzhausen JM
    Am J Emerg Med; 2022 Dec; 62():49-54. PubMed ID: 36252310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction.
    Hirschy R; Ackerbauer KA; Peksa GD; O'Donnell EP; DeMott JM
    Am J Emerg Med; 2019 Jan; 37(1):80-84. PubMed ID: 29731345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute rate control with metoprolol versus diltiazem in atrial fibrillation with heart failure with reduced ejection fraction.
    Kapustova K; Phan B; Allison-Aipa T; Choi M
    Am J Emerg Med; 2023 May; 67():126-129. PubMed ID: 36871480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.
    Hasbrouck M; Nguyen TT
    Am J Emerg Med; 2022 Aug; 58():39-42. PubMed ID: 35623182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate.
    Nuñez Cruz S; DeMott JM; Peksa GD; Slocum GW
    Am J Emerg Med; 2021 Aug; 46():329-334. PubMed ID: 33092938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic comparison of intravenous push diltiazem versus metoprolol for atrial fibrillation rate control.
    Nicholson J; Czosnowski Q; Flack T; Pang PS; Billups K
    Am J Emerg Med; 2020 Sep; 38(9):1879-1883. PubMed ID: 32745920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: Metoprolol vs. Diltiazem.
    Hargrove KL; Robinson EE; Lusk KA; Hughes DW; Neff LA; Fowler AL
    Am J Emerg Med; 2021 Feb; 40():15-19. PubMed ID: 33338675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department.
    McGrath P; Kersten B; Chilbert MR; Rusch C; Nadler M
    Am J Emerg Med; 2021 Aug; 46():585-590. PubMed ID: 33257143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
    Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
    J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.
    Xiao SQ; Ibarra F; Cruz M
    Ann Pharmacother; 2022 Aug; 56(8):916-921. PubMed ID: 34738470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Prehospital Diltiazem for Atrial Fibrillation with Rapid Ventricular Response.
    Rodriguez A; Hunter CL; Premuroso C; Silvestri S; Stone A; Miller S; Zuver C; Papa L
    Prehosp Disaster Med; 2019 Jun; 34(3):297-302. PubMed ID: 31043186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving ventricular rate control in patients taking chronic beta-blocker therapy.
    Feeney ME; Rowe SLB; Mah ND; Barton CA; Ran R
    Am J Emerg Med; 2018 Jan; 36(1):110-113. PubMed ID: 29055615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation.
    Jandali MB
    Clin Drug Investig; 2018 Jun; 38(6):503-508. PubMed ID: 29478238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intravenous calcium with diltiazem for atrial fibrillation/flutter in the emergency department.
    Rossi N; Allen B; Hailu K; Kamataris K; Ryan C
    Am J Emerg Med; 2023 Feb; 64():57-61. PubMed ID: 36442264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies.
    Bolton A; Paudel B; Adhaduk M; Alsuhaibani M; Samuelson R; Schweizer ML; Hodgson-Zingman D
    Am J Cardiovasc Drugs; 2024 Jan; 24(1):103-115. PubMed ID: 37856044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of atrial flutter and atrial fibrillation with rapid ventricular response in patients with acute decompensated heart failure: A systematic review.
    Niforatos JD; Ehmann MR; Balhara KS; Hinson JS; Ramcharran L; Lobner K; Weygandt PL
    Acad Emerg Med; 2023 Feb; 30(2):124-132. PubMed ID: 36326565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Weight-Based Dose vs. Standard Dose Diltiazem in Patients with Atrial Fibrillation Presenting to the Emergency Department.
    Ross AL; O'Sullivan DM; Drescher MJ; Krawczynski MA
    J Emerg Med; 2016 Oct; 51(4):440-446. PubMed ID: 27452987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of body weight on intravenous diltiazem in patients with atrial fibrillation with rapid ventricular response.
    Zimmerman DE; Jachim L; Iaria A; Brun C; Covvey JR
    J Clin Pharm Ther; 2018 Dec; 43(6):855-859. PubMed ID: 29956357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis.
    Sharda SC; Bhatia MS
    Indian Heart J; 2022; 74(6):494-499. PubMed ID: 36334652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data.
    Moskowitz A; Chen KP; Cooper AZ; Chahin A; Ghassemi MM; Celi LA
    Shock; 2017 Oct; 48(4):436-440. PubMed ID: 28328711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.